

HY-P9961 · 1 mg
MedChemExpress · Cat: HY-P9961
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/ofatumumab.html
Description
Ofatumumab is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity ADCC and complement-dependent cytotoxicity CDC in CD20-expressing B lymphocytes. Ofatumumab has strong lytic activity against CD20-positive B lymphocytes and eliminates CD20-positive tumor cells through ADCC and CDC. Ofatumumab is particularly effective against drug-resistant cells with low CD20 expression and can be applied to the research of chronic lymphocytic leukemia CLL .







